| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 10/06/2004 | CN1169520C Perforated microparticles and methods for use |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 09/30/2004 | WO2004062659A8 Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040191239 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/30/2004 | DE19941360B4 Entschlackungs- und/oder Regenerationsmittel Purification and / or regenerating agent |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461347A1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461059A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 09/29/2004 | EP1461033A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 09/29/2004 | EP1292288B1 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| 09/29/2004 | EP0983300B1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/29/2004 | EP0878199B1 Natural tea comprising alder and mountain ash extracts for treating the effects of alcoholic drinks |
| 09/29/2004 | CN1533433A Method for virus propagation |
| 09/29/2004 | CN1533277A Preventives or remedies for diseases caused by e NOS expression |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/23/2004 | WO2004080473A1 Extract of petasites japonicus having neuroprotective effect and antioxidant activity |
| 09/23/2004 | WO2004080449A1 Ultraviolet-induced active oxygen inhibitor |
| 09/23/2004 | WO2004080436A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | WO2004080429A2 Use of thiol-based compositions in ameliorating mucosal injury |
| 09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040185485 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 09/23/2004 | CA2518883A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/22/2004 | EP1459752A2 Bisdioxopiperazine for the treatment of accidental extravasation of anthracyclines |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1060174B1 Nitric oxide releasing chelating agents and their therapeutic use |
| 09/22/2004 | CN1531437A Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 09/22/2004 | CN1531429A Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 09/22/2004 | CN1530129A Health care Husheng capsules for human blood health |
| 09/22/2004 | CN1167423C Means for treating radiation injuries |
| 09/22/2004 | CN1167421C Medicinal composition containing pyrroloquinolinequinone for treating saturnism |
| 09/21/2004 | US6794137 Detecting exposure of a cell to ultraviolet radiation; obtain cells, screen for preferential gene expression, monitor cells for adjusted tubulin protein expression |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180102 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 09/16/2004 | US20040180001 antitumor |
| 09/15/2004 | EP1456214A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456163A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1455808A1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 09/15/2004 | EP1455778A2 Methods for the treatment of peripheral neural and vascular ailments |
| 09/15/2004 | EP1140077B1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/15/2004 | EP1133487B1 Antioxidants |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529606A Preparation containing seleniter or selenate for treating wound |
| 09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
| 09/15/2004 | CN1528304A Anisodine hydrobromide drop pill and preparing method thereof |
| 09/15/2004 | CN1166683C New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/10/2004 | WO2004076423A1 Growth promotion method |
| 09/10/2004 | WO2004076349A1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto |
| 09/10/2004 | WO2004075990A1 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
| 09/10/2004 | WO2004075907A2 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
| 09/10/2004 | CA2517575A1 Growth promotion method |
| 09/10/2004 | CA2517007A1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040175342 Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
| 09/08/2004 | EP1075281B1 Polyol-ifn-beta conjugates |
| 09/08/2004 | CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents |
| 09/08/2004 | CN1165545C Method for separating and extracting total flavone from goldenrain tree plant and its application |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165290C New medicine release system-liposolubility medicinal preparation |
| 09/07/2004 | US6787566 Breakers of advanced glycation endproducts |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/02/2004 | WO2004073722A1 Superoxide anion decomposing agent |
| 09/02/2004 | US20040172112 Methods for treating prostatitis |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040170714 Bauhinia extracts |
| 09/02/2004 | US20040170701 Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection |
| 09/02/2004 | US20040170611 culturing an autologous or allogenic dermal papilla cell in the presence of a Wnt polypeptide or a fragment or analog thereof, and grafting the cultured cell onto the skin |
| 09/02/2004 | US20040170568 Stabilized preparations for use in metered dose inhalers |
| 09/02/2004 | DE20220955U1 Composition useful for treating e.g. depression, anxiety, obsessive-compulsive disorder, obesity comprises N-formyl paroxetine and a paroxetine compound |
| 09/02/2004 | CA2518311A1 Superoxide anion scavenger |
| 09/01/2004 | EP1452175A1 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451197A1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo- 3.2.2 nonane derivatives, preparation and therapeutic use thereof |
| 09/01/2004 | EP1450796A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450781A1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 09/01/2004 | EP1450629A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 09/01/2004 | EP1261349A4 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP1047769B1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |